Ian Gilham

Ian Gilham is the Nonexecutive Chairman at Cytox Limited, a role that complements his extensive experience in the biotechnology and pharmaceutical sectors. He has a notable background in the research, development, and commercialization of diagnostic and pharmaceutical products.

Professional Background

• Leadership Roles: Ian has held various significant positions, including:

  • Chair of LifeArc Board of Trustees: He also chairs the Nominations and Board Financial Approvals Committees at LifeArc.
  • Non-executive Chair: He serves as the non-executive chair for several companies, including Genedrive plc, RevoNa Bio, and Pelago BioScience.
  • Former CEO: He was the CEO of Axis-Shield plc, where he led the company to a successful sale to Alere.

• Industry Experience: Ian has held global management roles at major firms such as Celltech, Amersham International, Abbott Laboratories, and GlaxoSmithKline (GSK). His expertise includes leading mergers and acquisitions and maintaining strong networks in fund management and investor relations.

Current Involvements

In addition to his role at Cytox Limited, Ian continues to contribute to various organizations within the biotechnology sector, leveraging his extensive experience to guide strategic initiatives and foster innovation.

For more detailed insights into his professional journey, you can view his LinkedIn profile here .1